Saudi’s Acwa Power signs MoU with China’s Huawei and Silk Road Fund
Category: #business  By Mateen Dalal  Date: 2019-02-27
  • share
  • Twitter
  • Facebook
  • LinkedIn

Saudi’s Acwa Power signs MoU with China’s Huawei and Silk Road Fund

Acwa Power develops such to allow the company to maintain its cost leadership and reputation.

Acwa Power, the Saudi Arabia based developer of power and water plants recently announced that it has entered into a deal with Huawei and Silk Road Fund of China while the Crown Prince, HRH Mohammed Bin Salman, who is also the Minister of Defense and VP of the Council of Ministers of Saudi Arabia, was on a tour of Beijing.

The memorandums of understanding (MoU) signed with the organizations are expected to pave the way for investments and technological advancements for Acwa, which is a public investment fund backed firm. It is being opined that the MoUs would prove to be beneficial in the building of power generation and desalinated water production plants, the focal points of business of the Saudi company.

Reportedly, Hang Zheng, Vice Premier of the State Council of China and HRH Mohammed Bin Salman both attended that MoU signing ceremony. Wang Yanzhi, CEO, Silk Road Fund and Mohammad Abdullah Abunayyan, Chairman, Acwa Power signed the agreement.

Sources close to the matter report that Silk Road Fund would be investing in the projects undertaken by Acwa Power Renewable Energy Holding Ltd. in countries like the UAE, South Africa, Jordan and Egypt, that come under China’s Belt and Road Initiative which is reportedly a trillion-dollar program.

On the other hand, the agreement between Acwa Power and Huawei will have both companies working together to utilize information and communication technology to digitize power plant management processes, improve the performance of solar photovoltaic projects of Acwa Power and boost overall efficiencies.

Apparently, Acwa Power adopted a centralized control and monitoring project in 2018 and the agreement with Huawei builds on this project as Huawei’s Fusion Solar system was deployed for the plant’s management, monitoring, and control.

Paddy Padmanathan, President, Acwa Power has been reported to say that the company has progressively entered into collaborations with Chinese financial service providers, investors, engineering, procurement, and construction contractors and technology providers to deliver the company’s expanding utilities assets portfolio. He added that the synergies created through such agreements allow the company to maintain its cost leadership and reputation.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

AstraZenecas Farxiga gets fast track status to treat heart failure
AstraZenecas Farxiga gets fast track status to treat heart failure
By Mateen Dalal

With heart related issues and number of people diagnosed with heart failure increasing substantially, the need to find a solution to this problem is growing considerably. Advanced technology, equipment and pharmaceutical companies are continuously wo...

Upstream Works, Aceyus to pioneer customer experience solutions
Upstream Works, Aceyus to pioneer customer experience solutions
By Mateen Dalal

Customer Experience (CX) is vital for companies to understand the mindset of their clients. Industries are actively investing in customer experience solutions to stay ahead in competition. Companies are also partnering with other market players to en...

Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW
Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW
By Mateen Dalal

Patients having Relapsed-refractory multiple myeloma (RRMM) along with extramedullary disease (EMD) will be treated by Oncopeptides AB. In the company’s HORIZON trial, a cumulative response rate of 23% was attained with dexamethasone and mel...